Exact Mass: 430.0222

Exact Mass Matches: 430.0222

Found 106 metabolites which its exact mass value is equals to given mass value 430.0222, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Bicalutamide

4-Cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3-(trifluoromethyl)propionanilide

C18H14F4N2O4S (430.061)

Bicalutamide is only found in individuals that have used or taken this drug. It is an oral non-steroidal anti-androgen for prostate cancer. It binds to the androgen receptor.Bicalutamide competes with androgen for the binding of androgen receptors, consequently blocking the action of androgens of adrenal and testicular origin which stimulate the growth of normal and malignant prostatic tissue. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

CMP-2-aminoethylphosphonate

(2-aminoethyl)[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphinic acid

C11H20N4O10P2 (430.0655)

This compound belongs to the family of Pyrimidine Ribonucleoside Diphosphates. These are pyrimidine ribobucleotides with diphosphate group linked to the ribose moiety.

A - Alimentary tract and metabolism > A12 - Mineral supplements > A12A - Calcium > A12AA - Calcium C78275 - Agent Affecting Blood or Body Fluid > C29730 - Electrolyte Replacement Agent D - Dermatologicals

Dinitrostilbenedisulfonic acid

5-nitro-2-[2-(4-nitro-2-sulfophenyl)ethenyl]benzene-1-sulfonic acid

C14H10N2O10S2 (429.9777)

Acetamide, N-(4-((6-(4-(trifluoromethyl)phenyl)-4-pyrimidinyl)oxy)-2-benzothiazolyl)-

N-[4-({6-[4-(trifluoromethyl)phenyl]pyrimidin-4-yl}oxy)-1,3-benzothiazol-2-yl]acetamide

C20H13F3N4O2S (430.0711)

Calcium gluconate

Calcium bis(2,3,4,5,6-pentahydroxyhexanoic acid)

C12H22CaO14 (430.0635)

Food additive: firming agent, sequestrant, stabiliser, texturiser. Anticaking agent in powdered coffee↵↵Calcium gluconate is a mineral supplement. It is the form of calcium most widely used in the treatment of hypocalcemia. Calcium gluconate contains 9.3\\% calcium. It is also used to counteract an overdose of magnesium sulfate, often administered to pregnant women experiencing premature labor to slow or stop contractions. Excess magnesium sulfate can cause respiratory depression, for which calcium gluconate would be the antidote. Food additive: firming agent, sequestrant, stabiliser, texturiser. Anticaking agent in powdered coffee

6-(8-Umbelliferyl)apigenin

8-[5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-6-yl]-7-hydroxy-2H-1-benzopyran-2-one

C24H14O8 (430.0689)

8-(6-Umbelliferyl)apigenin

6-[5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-8-yl]-7-hydroxy-2H-1-benzopyran-2-one

C24H14O8 (430.0689)

1-Deacetoxyalgoane

(+)-1-Deacetoxyalgoane

C15H25Br2ClO2 (429.991)

Deodactol

C15H25Br2ClO2 (429.991)

Isocespitol

[2R-[2a(1S*,3R*,4R*),3alpha,5beta]]- 5-Bromo-2-(4-bromo-3-chloro-4-methylcyclohexyl)tetrahydro-2,6,6-trimethyl-2H-pyran-3-ol

C15H25Br2ClO2 (429.991)

2-((2-(4-Bromophenyl)-2-oxoethyl)sulfanyl)-3-isobutyl-4(3H)-quinazolinone

C20H19BrN2O2S (430.0351)

ZINC12370117

C19H15ClN4O4S (430.0503)

Oprea1_310099

C20H15ClN2O5S (430.039)

Maybridge1_000292

C22H20Cl2N2OS (430.0673)

Maybridge1_001913

C14H8F6N2O5S (430.0058)

Methyl dichloroasterrate

C18H16Cl2O8 (430.0222)

SANGUINARINE SULFATE

C20H16NO8S+ (430.0597)

9-Acetoxymethyl-4,6-diformyl-3,8-dihydroxy-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carbonsaeure|9-acetoxymethyl-4,6-diformyl-3,8-dihydroxy-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carboxylic acid

9-Acetoxymethyl-4,6-diformyl-3,8-dihydroxy-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carbonsaeure|9-acetoxymethyl-4,6-diformyl-3,8-dihydroxy-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carboxylic acid

C20H14O11 (430.0536)

6-(8-Umbelliferyl)-apigenin

C24H14O8 (430.0689)

Galbinic acid

C20H14O11 (430.0536)

CHEMBL3941463

C24H14O8 (430.0689)

(2R,3S,4R,5S,6S,7R,E)-2,3,5,6,7,15-hexachloropentadec-14-en-4-ol

C15H24Cl6O (429.9958)

5-{4-[4-(5-pent-1,3-diynylthiophen-2-yl)-but-3-ynyloxy]-but-1-ynyl}-2,2-bithiophene|echinoetherthiophene

C25H18OS3 (430.052)

14-hydroxy-8beta-(3-chloro-2-hydroxyisobutyryloxy)-3-chlorodehydroleucodin|14-hydroxy-8beta-<3-chloro-2-hydroxyisobutyryloxy>-3-chlorodehydroleucodin

C19H20Cl2O7 (430.0586)

diphosphoric acid-1-(2-amino-ethyl ester)-2-(2-deoxy-cytidin-5-yl ester)|Diphosphorsaeure-1-(2-amino-aethylester)-2-(2-desoxy-cytidin-5-ylester)

C11H20N4O10P2 (430.0655)

C18H24Br2O2

C18H24Br2O2 (430.0143)

2,10-Dibromo-3-chloro-5,7-chamigranediol

C15H25Br2ClO2 (429.991)

Bicalutamide

(2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide

C18H14F4N2O4S (430.061)

L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4405; ORIGINAL_PRECURSOR_SCAN_NO 4401 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4432; ORIGINAL_PRECURSOR_SCAN_NO 4429 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4382; ORIGINAL_PRECURSOR_SCAN_NO 4377 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4426; ORIGINAL_PRECURSOR_SCAN_NO 4422 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4399; ORIGINAL_PRECURSOR_SCAN_NO 4398 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4400; ORIGINAL_PRECURSOR_SCAN_NO 4397 CONFIDENCE standard compound; INTERNAL_ID 2349 CONFIDENCE standard compound; INTERNAL_ID 8615 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2809

methyl 3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate

NCGC00347615-02!methyl 3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate

C18H16Cl2O8 (430.0222)

methyl 3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate [IIN-based: Match]

NCGC00347615-02!methyl 3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate [IIN-based: Match]

C18H16Cl2O8 (430.0222)

methyl 3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate [IIN-based on: CCMSLIB00000847501]

NCGC00347615-02!methyl 3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate [IIN-based on: CCMSLIB00000847501]

C18H16Cl2O8 (430.0222)

h_298_bicalutamide

C18H14F4N2O4S (430.061)

Cys Cys Cys Cys

(2R)-2-[(2R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C12H22N4O5S4 (430.0473)

Methyl 2,4-dichloroasterrate

C18H16Cl2O8 (430.0222)

DNDS

4,4-dinitrostilbene-2,2-disulfonic acid

C14H10N2O10S2 (429.9777)

SNS-314

C18H15ClN6OS2 (430.0437)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor